However, the factors: TNF-α, IL1β, Nox4, NPT, M1 macrophages, MMP9, and increase in CD4+ and CD8+ cells may be affected in DMD patients and the TAK242 treated mice. This evidence concerns the gene MMP9 and Duchenne muscular dystrophy.